Chris leads strategy and scale at Fourth Eon. He’s spent two decades at the intersection of frontier technology, infrastructure development, and global security. He co-founded and scaled AMPLYFI, a venture-backed AI company partnering with international defense agencies, and previously led disruptive technology assessment and energy policy at BP. He is a DARPA SWITCH Advisor, Innovate UK Council Member, and a Big if True Science Fellow at Renaissance Philanthropy. Chris holds a BA in History from SUNY New Paltz and an MSc in International & European Politics from the University of Edinburgh.

Gary leads research and development at Fourth Eon. His expertise spans chemistry, molecular biophysics, biosecurity, and sequencing technology. He’s spent nearly two decades studying how DNA, RNA, and proteins behave and interact. He is also a Contributing Scholar at the Johns Hopkins Center for Health Security, supporting the Center’s work to understand and mitigate global biological risks from advanced AI. Gary holds a BS in Physics from San Jose State University and a PhD in Chemistry from University of California Merced.

James is a founding Scientific Advisor and co-inventor of the adaptive screening method. He is also a Contributing Scholar at Johns Hopkins Center for Health Security. He is a medical doctor and computational biologist with expertise in biosecurity, evolutionary biology, and genotype-phenotype relationships. James holds a BA in Medical Sciences from Oxford University, an MBBS from Imperial College London, and a PhD in Computational Cancer Genomics from University College London.

Chris recently completed his DPhil in Biochemistry at the University of Oxford, where he specialized in viral protein dynamics with biomolecular NMR spectroscopy. Chris is now investigating biosecurity risks brought by the rapid development of AI tools, particularly at the interface of structural and computational biology, and is funded by Coefficient Giving’s Career Transition Fellowship program. Chris holds a BSc in Biochemistry from Imperial College London and a MSc by Research in Biochemistry from the University of Oxford.

Elias recently completed his MSc in Computational Biology and Bioinformatics from ETH Zürich, where he specialized in ML for protein design. He is interested in AI capabilities and biosecurity risk. He has contributed to publications on LLM risks in agriculture and computational methods in ecology. Previously, he worked at McKinsey on geospatial analytics and generative AI for agriculture.

Hanna is a PhD student in Mathematical Epidemiology at the University of Warwick, applying ML to syndromic surveillance data for early outbreak detection with the UK Health Security Agency. Beyond this, their biosecurity work includes co-developing an AI Know-Your-Customer tool for DNA providers, scoping a research programme for function-based screening of nucleic acid sequences with the Centre for Long-Term Resilience, and AI-bio threat modelling as a GovAI Winter Fellow. They hold a BSc in Biology and Philosophy from the University of St Andrews.

Ian is a Physics Professor at the University of North Carolina Greensboro, with experience in Physics Education Research and Computational Physics. Driven by a desire to make the world safer, he’s diving into the AI-biosecurity nexus, trying to reduce catastrophic pandemic risk by improving DNA synthesis screening methods. Ian holds a PhD in Physics from the University of Massachusetts Amherst.

Isha is a medical student at the University of Cambridge, with an undergraduate degree in Biochemistry. She has research experience in viral genomics and cancer immunology, and is applying her computational background to biosecurity as a SPAR research fellow.

Jack develops infectious disease diagnostics at Strive Bioscience, an early-stage startup. He’s previously built sequence filtration software for SecureBio Detection, researched virulence factors to inform DNA screening standards, and founded an iGEM team at the University of Arizona, where he’s also completing a B.S. in biology. He’s also interested in PPE, function-based synthesis screening, and transmission suppression technologies.

Jack develops infectious disease diagnostics at Strive Bioscience, an early-stage startup. He’s previously built sequence filtration software for SecureBio Detection, researched virulence factors to inform DNA screening standards, and founded an iGEM team at the University of Arizona, where he’s also completing a B.S. in biology. He’s also interested in PPE, function-based synthesis screening, and transmission suppression technologies.